Characterization of the human cysteinyl leukotriene CysLT1 receptor (Q22010199)

GOA release 2020-03-11

K R Lynch

1

Kevin R.

Lynch

1 reference

6 February 2023

G P O'Neill

2

Gary P.

O'Neill

1 reference

6 February 2023

Q Liu

3

Qingyun

Liu

1 reference

6 February 2023

D S Im

4

Dong-Soon

Im

1 reference

6 February 2023

N Sawyer

5

Nicole

Sawyer

1 reference

6 February 2023

K M Metters

6

Kathleen M.

Metters

1 reference

6 February 2023

N Coulombe

7

Nathalie

Coulombe

1 reference

6 February 2023

M Abramovitz

8

Mark

Abramovitz

1 reference

6 February 2023

D J Figueroa

9

David J.

Figueroa

1 reference

6 February 2023

Z Zeng

10

Zhizhen

Zeng

1 reference

6 February 2023

B M Connolly

11

Brett M.

Connolly

1 reference

6 February 2023

C Bai

12

Chang

Bai

1 reference

6 February 2023

C P Austin

13

Christopher P.

Austin

1 reference

6 February 2023

A Chateauneuf

14

Anne

Chateauneuf

1 reference

6 February 2023

R Stocco

15

Rino

Stocco

1 reference

6 February 2023

G M Greig

16

Gillian M.

Greig

1 reference

6 February 2023

S Kargman

17

Stacia

Kargman

1 reference

6 February 2023

S B Hooks

18

Shelley B.

Hooks

1 reference

6 February 2023

E Hosfield

19

Elizabeth

Hosfield

1 reference

6 February 2023

D L Williams

20

David L.

Williams

1 reference

6 February 2023

A W Ford-Hutchinson

21

Anthony W.

Ford-Hutchinson

1 reference

6 February 2023

C T Caskey

22

C. Thomas

Caskey

1 reference

6 February 2023

J F Evans

23

Jilly F.

Evans

1 reference

Leukotrienes are potent constrictors of human bronchi

6 February 2023

language of work or name

English

0 references

publication date

24 June 1999

0 references

published in

Nature

0 references

volume

399

0 references

issue

6738

0 references

page(s)

789-93

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2F21658

7 January 2021

Formation and actions of leukotrienes

1 reference

https://api.crossref.org/works/10.1038%2F21658

7 January 2021

Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases

1 reference

https://api.crossref.org/works/10.1038%2F21658

7 January 2021

Effects of L-serine borate on antagonism of leukotriene C4-induced contractions of guinea-pig trachea

1 reference

https://api.crossref.org/works/10.1038%2F21658

7 January 2021

Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist

1 reference

https://api.crossref.org/works/10.1038%2F21658

7 January 2021

Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group

1 reference

https://api.crossref.org/works/10.1038%2F21658

7 January 2021

Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group

1 reference

https://api.crossref.org/works/10.1038%2F21658

7 January 2021

Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction

1 reference

https://api.crossref.org/works/10.1038%2F21658

7 January 2021

Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2F21658

7 January 2021

Results of the first U.S. double-blind, placebo-controlled, multicenter clinical study in asthma with pranlukast, a novel leukotriene receptor antagonist

1 reference

https://api.crossref.org/works/10.1038%2F21658

7 January 2021

A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis

1 reference

https://api.crossref.org/works/10.1038%2F21658

7 January 2021

Leukotriene binding, signaling, and analysis of HIV coreceptor function in mouse and human leukotriene B4 receptor-transfected cells

1 reference

https://api.crossref.org/works/10.1038%2F21658

7 January 2021

Improved tools for biological sequence comparison

1 reference

https://api.crossref.org/works/10.1038%2F21658

7 January 2021

Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist

1 reference

https://api.crossref.org/works/10.1038%2F21658

7 January 2021

Functional expression and characterization of human D2 and D3 dopamine receptors

1 reference

https://api.crossref.org/works/10.1038%2F21658

7 January 2021

Characterization of the leukotriene D4 receptor in dimethylsulphoxide-differentiated U937 cells: comparison with the leukotriene D4 receptor in human lung and guinea-pig lung

1 reference

https://api.crossref.org/works/10.1038%2F21658

7 January 2021

Leukotriene receptors

1 reference

https://api.crossref.org/works/10.1038%2F21658

7 January 2021

Responses to sphingosine-1-phosphate in X. laevis oocytes: similarities with lysophosphatidic acid signaling

1 reference

https://api.crossref.org/works/10.1038%2F21658

7 January 2021

Characterization of a receptor subtype-selective lysophosphatidic acid mimetic

1 reference

https://api.crossref.org/works/10.1038%2F21658

7 January 2021

Characterization of the recombinant human prostanoid DP receptor and identification of L-644,698, a novel selective DP agonist

1 reference

https://api.crossref.org/works/10.1038%2F21658

7 January 2021

An automated aequorin luminescence-based functional calcium assay for G-protein-coupled receptors

1 reference

COCI